Burden of Acute Viral Hepatitis - China, 1990-2019

Shicheng Yu; Qiqi Wang; Shujun Wang; Jiaojiao Zhang; Yuehua Hu; Junqi Li; Xiaojuan Long; Xianglong Xiang; Maigeng Zhou; Feng Tan

doi:10.46234/ccdcw2020.156

Burden of Acute Viral Hepatitis - China, 1990-2019

China CDC Wkly. 2020 Jul 31;2(31):579-586. doi: 10.46234/ccdcw2020.156.

Authors

Affiliations

¹ Office of Epidemiology, Chinese Center for Disease Control and Prevention, Beijing, China.
² National Center for Chronic and Non-Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
³ Department of Academic Publishing, Chinese Center for Disease Control and Prevention, Beijing, China.

Abstract

What is already known about this topic?

The World Health Organization's (WHO) Global Health Estimates (GHE) reported that acute hepatitis caused 9,213 deaths and 307,720 person years of disability-adjusted life years (DALYs) in 2016, and acute hepatitis B accounted for 85.81% of all DALYs among acute hepatitis types A, B, C, and E in China.

What is added by this report?

In China, the percent changes in years lived with disability (YLDs) due to acute hepatitis A, B, and E in groups aged 50-69 years and 70 years or more and in all age groups for acute hepatitis C were increased from 2000 to 2019.

What are the implications for public health practices?

Eﬀective vaccines, interventions, and treatments are key approaches to achieve the WHO's goal of reducing new hepatitis infections by 90% and deaths by 65% between 2016 and 2030.

Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2020.

Grants and funding

This study is supported by National Key Research and Development Program “Applied Study on the Data-driven Prevention and Control Strategies of the Major Chronic Diseases” (2018YFC1315305).